Physician
Alao, Oladipo
Alao, Oladipo was paid $30K by Medicaid between Jan 2021 and Oct 2024, across 7 billing codes. Its largest line is 99204, doctor's office visit, new patient (more involved) — 50% of everything it billed.
33Billing provider infoALAO, OLADIPO
WEST NYACK, NY 10994
WEST NYACK, NY 10994
33aNPI1265539993assigned 09/17/2006
33bProvider typeInfectious Disease Physician
28Total paid$30K
24GClaims254
24DCodes billed7
24AFirst – last monthJan 2021 – Oct 2024
Compared with peers
Next to other Infectious Disease Physician providers in New York
Rank by total paid#78 of 333
Median peer was paid$7K
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 90 | $13K | |
| 2022 | 131 | $16K | |
| 2024incomplete | 33 | $427.64 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 50% | 80 | 80 | $15K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17% | 37 | 36 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12% | 27 | 27 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 60 | 56 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.5% | 18 | 18 | $1K |
| 87634 | 3.0% | 14 | 14 | $912.60 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.5% | 18 | 18 | $450.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.